The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Open accessAbstract
Iron is essential for many biological processes, including oxygen delivery, and its supply is tightly regulated. Hepcidin, a small peptide synthesized in the liver, is a key regulator of iron absorption and homeostasis in mammals. Hepcidin production is increased by iron overload and decreased by anemia and hypoxia; but the molecular mechanisms that govern the hepcidin response to these stimuli are not known. Here we establish that the von Hippel-Lindau/hypoxia-inducible transcription factor (VHL/HIF) pathway is an essential link between iron homeostasis and hepcidin regulation in vivo. Through coordinate downregulation of hepcidin and upregulation of erythropoietin and ferroportin, the VHL-HIF pathway mobilizes iron to support erythrocyte production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, HIF effects (via hepcidin) the mobilisation or iron and can cause the expression of inflammatory cytokines such as IL-1, IL-6 and TNF-α [2254-2256] under conditions (hypoxia) where superoxide and peroxide production are likely to be increased, and consequently increases sepsis (in that HIF-knockout mice are resistant to LPS-induced sepsis [2254,2255]).”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2254]
In the citing paper
“and several proteins induced by hypoxia such as hypoxia inducible factor-1 (HIF-1) or platelet derived growth factor BB (PDGF-BB) reduce hepcidin expression, thereby enhancing iron delivery for erythropoiesis (Peyssonnaux et al., 2007; Sonnweber et al., 2014).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Peyssonnaux et al., 2007
In the citing paper
“The von Hippel-Lindau/hypoxia-inducible transcription factor (HIF) system also appears to control hepcidin expression, with HIF1␣ acting as a repressor when it binds to the hepcidin promoter.109”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [109]
In the citing paper
“Experimental studies in cultured cells, in animal models and in human subjects have established that hepcidin production is O2-sensitive and involves the HIF pathway.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [193]
In the citing paper
“Subsequent investigation revealed that Nrf2 and AP1 family transcription factors, in conjunction with transcriptional coactivator p300/CBP, are involved in the activation of the ARE (246, 302, 306, 307)”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [246]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 1×
“As Albumin-Cre/VHLflox/flox mice exhibit hepatic inflammation and steatosis (21) (Figure 2C), we examined levels of the proinflammatory cytokine IL-6, which is known to stimulate hepcidin expression and may contribute to the anemia of chronic inflammation (5).”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J. S., Hanif, A., Bajantri, B., & Chilimuri, S. S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,353
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,301
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Self-citation
Flagged first, then by citations
Research works printed but not linked: 4
- Gu, 1998, Gene Expr., 7, 205
- Wenger, 1997, Biol. Chem., 378, 609
- Mazure, 2002, Cancer Res., 62, 1158
- Brugnara, 1994, J. Lab. Clin. Med., 123, 660
Cited by
Sorted by citations
Items 101–200 of 637
Finberg, K. E., Whittlesey, R. L., Fleming, M. D., & Andrews, N. C. (2010) · Blood · doi:10.1182/blood-2009-05-224808 · Cited by 167
Review article: the iron overload syndromes
Siddique, A., & Kowdley, K. V. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05051.x · Cited by 162
State of the Science: An Update on Renal Cell Carcinoma
Jonasch, E. W., Futreal, P. A., Davis, I. J., Bailey, S. T., Kim, W. Y., Brugarolas, J., Giaccia, A. J., Kurban, G., Pause, A., Frydman, J., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0117 · Cited by 165
Mastrogiannaki, M., Matak, P., Mathieu, J. R. R., Delga, S., Mayeux, P., Vaulont, S., & Peyssonnaux, C. (2011) · Haematologica · doi:10.3324/haematol.2011.056119 · Cited by 171
Self-citationHIF‐prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism
Haase, V. H. (2017) · Hemodialysis International · doi:10.1111/hdi.12567 · Cited by 164
Self-citationHepcidin-ferroportin axis in health and disease
Ginzburg, Y. Z. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.002 · Cited by 171
Iron Homeostasis: Recently Identified Proteins Provide Insight into Novel Control Mechanisms
Zhang, A.-S., & Enns, C. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800017200 · Cited by 154
Iron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
Piperno, A., Galimberti, S., Mariani, R., Pelucchi, S., Ravasi, G., Lombardi, C., Bilo, G., Revera, M., Giuliano, A., Faini, A., et al. (2011) · Blood · doi:10.1182/blood-2010-08-299859 · Cited by 151
The VHL tumor suppressor and HIF: insights from genetic studies in mice
Kapitsinou, P. P., & Haase, V. H. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402313 · Cited by 151
Self-citationIron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities
Zhang, C., & Zhang, F. (2014) · Protein & Cell · doi:10.1007/s13238-014-0119-z · Cited by 149
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.-M., Kleinsasser, A., Burtscher, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305317 · Cited by 145
Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia
Bartoszewska, S., & Collawn, J. F. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00212-1 · Cited by 152
Anemia in malignancies: Pathogenetic and diagnostic considerations
Gaspar, B. L., Sharma, P., & Das, R. (2014) · Hematology · doi:10.1179/1607845414y.0000000161 · Cited by 149
Iron homeostasis and organismal aging
Zeidan, R. S., Han, S. M., Leeuwenburgh, C., & Xiao, R. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101510 · Cited by 155
Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2
Yang, X., Park, S., Chang, H., Shapiro, J. S., Vassilopoulos, A., Sawicki, K. T., Chen, C., Shang, M., Burridge, P. W., Epting, C. L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88574 · Cited by 148
Molecular mechanisms of normal iron homeostasis
Zhang, A.-S., & Enns, C. A. (2009) · Hematology · doi:10.1182/asheducation-2009.1.207 · Cited by 147
Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin
Pietrangelo, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.045 · Cited by 136
The genetics of essential metal homeostasis during development
Kambe, T., Weaver, B. P., & Andrews, G. K. (2008) · genesis · doi:10.1002/dvg.20382 · Cited by 140
Viatte, L., & Vaulont, S. (2009) · Biochimie · doi:10.1016/j.biochi.2009.06.012 · Cited by 140
Self-citationThe Regulation of Hepcidin and Its Effects on Systemic and Cellular Iron Metabolism
Fleming, M. D. (2008) · Hematology · doi:10.1182/asheducation-2008.1.151 · Cited by 134
Iron Regulatory Proteins: From Molecular Mechanisms to Drug Development
Recalcati, S., Minotti, G., & Cairo, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2983 · Cited by 127
SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression
Mleczko‐Sanecka, K., Casanovas, G., Ragab, A., Breitkopf, K., Müller, A., Boutros, M., Dooley, S., Hentze, M. W., & Muckenthaler, M. U. (2009) · Blood · doi:10.1182/blood-2009-09-238105 · Cited by 124
Iron deficiency syndromes and iron‐restricted erythropoiesis (CME)
Goodnough, L. T. (2011) · Transfusion · doi:10.1111/j.1537-2995.2011.03495.x · Cited by 121
Emerging and Dynamic Biomedical Uses of Ferritin
Chiou, B., & Connor, J. R. (2018) · Pharmaceuticals · doi:10.3390/ph11040124 · Cited by 119
Dysregulated iron metabolism in polycythemia vera: etiology and consequences
Ginzburg, Y. Z., Feola, M., Zimran, E., Várkonyi, J., Ganz, T., & Hoffman, R. (2018) · Leukemia · doi:10.1038/s41375-018-0207-9 · Cited by 118
Roxadustat for CKD-related Anemia in Non-dialysis Patients
Coyne, D. W., Roger, S. D., Shin, S. K., Kim, S. G., Cadena, A., Moustafa, M. A., Chan, T. M., Besarab, A., Chou, W., Bradley, C., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.11.034 · Cited by 126
RetractedHepcidin in human iron disorders: Therapeutic implications
Pietrangelo, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.004 · Cited by 115
Hepcidin modulation in human diseases: From research to clinic
Piperno, A., Mariani, R., Trombini, P., & Girelli, D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.538 · Cited by 117
The essential nature of iron usage and regulation
Kaplan, J., & Ward, D. M. (2013) · Current Biology · doi:10.1016/j.cub.2013.05.033 · Cited by 115
Cercamondi, C. I., Egli, I. M., Ahouandjinou, E., Dossa, R. A. M., Zeder, C., Salami, L., Tjalsma, H., Wiegerinck, E. T. G., Tanno, T., Hurrell, R. F., et al. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.30051 · Cited by 114
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
Lakhal‐Littleton, S., Schödel, J., Townsend, A., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173096 · Cited by 119
Erythropoietin and erythropoiesis
Fried, W. I. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.05.010 · Cited by 119
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Hirota, K. (2021) · Biomedicines · doi:10.3390/biomedicines9050468 · Cited by 115
Li, L.-X., Guo, F., Liu, H., & Zeng, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04239-9 · Cited by 113
Hirota, K. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.018 · Cited by 106
Rychtarcikova, Z., Lettlova, S., Tomkova, V., Korenkova, V., Langerova, L., Simonova, E., Zjablovskaja, P., Alberich-Jorda, M., Neuzil, J., & Truksa, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14093 · Cited by 100
Akizawa, T., Tsubakihara, Y., Nangaku, M., Endo, Y., Nakajima, H., Kohno, T., Imai, Y., Kawase, N., Hara, K., Lepore, J. J., et al. (2016) · American Journal of Nephrology · doi:10.1159/000454818 · Cited by 105
Regulation of iron pathways in response to hypoxia
Chepelev, N. L., & Willmore, W. G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.023 · Cited by 106
New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases
Williams, J., Manley, S., & Ding, W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12908 · Cited by 102
Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
Kaplan, J., Sharma, N., & Dikdan, S. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020389 · Cited by 108
Anaemia, iron deficiency and susceptibility to infections
Jonker, F. A. M., & van Hensbroek, M. B. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.08.007 · Cited by 110
Hepcidin: clinical utility as a diagnostic tool and therapeutic target
Coyne, D. W. (2011) · Kidney International · doi:10.1038/ki.2011.141 · Cited by 97
Iron-Sensing Proteins that Regulate Hepcidin and Enteric Iron Absorption
Knutson, M. D. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104801 · Cited by 96
Hereditary hemochromatosis in the post- HFE era
Olynyk, J. K., Trinder, D., Ramm, G. A., Britton, R. S., & Bacon, B. R. (2008) · Hepatology · doi:10.1002/hep.22507 · Cited by 97
Iron metabolism: current facts and future decisions
Tandara, L., & Salamunić, I. (2012) · Biochemia Medica · doi:10.11613/bm.2012.034 · Cited by 102
Interacting signals in the control of hepcidin expression
Darshan, D., & Anderson, G. J. (2009) · BioMetals · doi:10.1007/s10534-008-9187-y · Cited by 95
Volke, M., Gale, D. P., Maegdefrau, U., Schley, G., Klanke, B., Bosserhoff, A.-K., Maxwell, P. H., Eckardt, K.-U., & Warnecke, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007875 · Cited by 93
Regulation of hepcidin expression at high altitude
Talbot, N. P., Lakhal, S., Smith, T. G., Privat, C., Nickol, A. H., Rivera-Ch, M., León-Velarde, F., Dorrington, K. L., Mole, D. R., & Robbins, P. A. (2012) · Blood · doi:10.1182/blood-2011-03-341776 · Cited by 93
Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease
Daher, R., Manceau, H., & Karim, Z. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.006 · Cited by 92
Iron Loading and Overloading due to Ineffective Erythropoiesis
Tanno, T., & Miller, J. L. (2010) · Advances in Hematology · doi:10.1155/2010/358283 · Cited by 94
Pathophysiology and treatment of patients with beta-thalassemia – an update
Fibach, E., & Rachmilewitz, E. A. (2017) · F1000Research · doi:10.12688/f1000research.12688.1 · Cited by 94
A general map of iron metabolism and tissue-specific subnetworks
Hower, V., Mendes, P., Torti, F. M., Laubenbacher, R., Akman, S. A., Shulaev, V., & Torti, S. V. (2009) · Molecular BioSystems · doi:10.1039/b816714c · Cited by 97
Expression of iron-related genes in human brain and brain tumors
Hänninen, M., Haapasalo, J. A., Haapasalo, H. K., Fleming, R. E., Britton, R. S., Bacon, B. R., & Parkkila, S. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-36 · Cited by 91
de Mast, Q., Nadjm, B., Reyburn, H., Kemna, E. H. J. M., Amos, B., Laarakkers, C. M. M., Silalye, S., Verhoef, H., Sauerwein, R. W., Swinkels, D. W., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/595790 · Cited by 89
Bajbouj, K., Shafarin, J., & Hamad, M. A. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818764470 · Cited by 89
Multiple Hepcidins in a Teleost Fish, Dicentrarchus labrax: Different Hepcidins for Different Roles
Neves, J. V., Caldas, C., Vieira, I. H., Ramos, M. F., & Rodrigues, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501153 · Cited by 92
Rosager, A. M., Sørensen, M. D., Dahlrot, R. H., Hansen, S., Schonberg, D. L., Rich, J. N., Lathia, J. D., & Kristensen, B. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182954 · Cited by 84
Nonrenal regulation of EPO synthesis
Weidemann, A., & Johnson, R. S. (2009) · Kidney International · doi:10.1038/ki.2008.687 · Cited by 87
Self-citationManagement of Iron-Deficiency Anemia in Inflammatory Bowel Disease
Nielsen, O. H., Ainsworth, M. A., Coskun, M., & Weiß, G. (2015) · Medicine · doi:10.1097/md.0000000000000963 · Cited by 92
Joshi, H. P., Subramanian, I. V., Schnettler, E. K., Ghosh, G., Rupaimoole, R., Evans, C., Saluja, M., Jing, Y., Ivan, C., Roy, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317242111 · Cited by 87
Sato, T., Chang, H., Bayeva, M., Shapiro, J. S., Ramos-Alonso, L., Kouzu, H., Jiang, X., Liu, T., Yar, S., Sawicki, K. T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804701115 · Cited by 87
Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
Nemeth, E. (2009) · Advances in Hematology · doi:10.1155/2010/750643 · Cited by 88
Oxidative Stress in β-Thalassemia
Fibach, E., & Dana, M. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0373-5 · Cited by 92
Micromanaging Iron Homeostasis
Yoshioka, Y., Kosaka, N., Ochiya, T., & Kato, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356717 · Cited by 86
Yan, L. Y., Colandrea, V. J., & Hale, J. J. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2010.510836 · Cited by 87
Akizawa, T., Iwasaki, M., Otsuka, T., Reusch, M., & Misumi, T. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00943-4 · Cited by 86
Ahmad, T., Kumar, M., Mabalirajan, U., PATTNAIK, B. R., Aggarwal, S., Singh, R., Singh, S., Mukerji, M., Ghosh, B., & Agrawal, A. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0203oc · Cited by 83
Nemeth, E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05585.x · Cited by 91
Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies
Taher, A. T., Hershko, C., & Cappellini, M. D. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07848.x · Cited by 81
Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
Watts, D., Gaete, D., Rodriguez, D., Hoogewijs, D., Rauner, M., Sormendi, S., & Wielockx, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218131 · Cited by 90
Iron Homeostasis and Its Interaction with Prolyl Hydroxylases
Mole, D. R. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2790 · Cited by 80
The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling
Jones, R. B., Dorsett, K. A., Hjelmeland, A. B., & Bellis, S. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001194 · Cited by 83
Regulation of Hepcidin by Erythropoiesis: The Story So Far
Pasricha, S., McHugh, K., & Drakesmith, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050731 · Cited by 84
Weinreb, O., Amit, T., Mandel, S. A., Kupershmidt, L., & Youdim, M. B. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2929 · Cited by 80
Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
Swinkels, D. W., & Wetzels, J. F. M. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn267 · Cited by 79
β-Thalassemia intermedia: a comprehensive overview and novel approaches
Asadov, C. D., Alimirzoyeva, Z., Mammadova, T., Aliyeva, G., Gafarova, S., & Mammadov, J. (2018) · International Journal of Hematology · doi:10.1007/s12185-018-2411-9 · Cited by 81
Systemic VHL gene functions and the VHL disease
Bader, H. L., & Hsu, T. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.032 · Cited by 81
NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis
Duarte, T. L., Talbot, N. P., & Drakesmith, H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8148 · Cited by 77
Recycling Iron in Normal and Pathological States
Beaumont, C., & Delaby, C. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.004 · Cited by 84
HIF prolyl hydroxylase inhibitors for anemia
Muchnik, E., & Kaplan, J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.566861 · Cited by 76
Theurl, I., Schroll, A., Nairz, M., Seifert, M., Theurl, M., Sonnweber, T., Kulaksiz, H., & Weiss, G. (2011) · Haematologica · doi:10.3324/haematol.2011.048926 · Cited by 77
Iron, hepcidin, and the metal connection
Loréal, O., Cavey, T., Bardou‐Jacquet, E., Guggenbuhl, P., Ropert, M., & Brissot, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00128 · Cited by 78
Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease
Nielsen, O. H., Soendergaard, C., Vikner, M. E., & Weiß, G. (2018) · Nutrients · doi:10.3390/nu10010082 · Cited by 76
Mleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., et al. (2014) · Blood · doi:10.1182/blood-2013-07-515957 · Cited by 74
Iron overload in hematological disorders
Fibach, E., & Rachmilewitz, E. A. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.007 · Cited by 79
Akizawa, T., Nangaku, M., Yamaguchi, T., Arai, M., Koretomo, R., Matsui, A., & Hirakata, H. (2019) · American Journal of Nephrology · doi:10.1159/000496929 · Cited by 74
Romney, S. J., Newman, B. S., Thacker, C. M., & Leibold, E. A. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002394 · Cited by 76
Hepcidin: A novel peptide hormone regulating iron metabolism
Singh, B. M., Arora, S., Agrawal, P., & Gupta, S. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.014 · Cited by 77
-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
Melchiori, L., Gardenghi, S., & Rivella, S. (2010) · Advances in Hematology · doi:10.1155/2010/938640 · Cited by 77
The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD
Brookhart, M. A., Schneeweiß, S., Avorn, J., Bradbury, B. D., Rothman, K. J., Fischer, M. A., Mehta, J., & Winkelmayer, W. C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111181 · Cited by 74
Iron metabolism in thalassemia and sickle cell disease
Mariani, R., Trombini, P., Matteo Pozzi, & Piperno, A. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.006 · Cited by 76
Current strategies and progress for targeting the “undruggable” transcription factors
Zhuang, J., Liu, Q., Wu, D., & Tie, L. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00852-9 · Cited by 77
Hepatocyte toll-like receptor 4 mediates lipopolysaccharide-induced hepcidin expression
Lee, Y., Kim, Y., Jung, Y. S., Kim, K.-S., Kim, D., Na, S., Lee, J.-M., Lee, C., & Choi, H. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.207 · Cited by 71
Semenza, G. L. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-102602 · Cited by 74
Legendre, C., Hori, T., Loyer, P., Aninat, C., Ishida, S., Glaise, D., Lucas‐Clerc, C., Boudjéma, K., Guguen‐Guillouzo, C., Corlu, A., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.010 · Cited by 73
Iron and liver cancer: an inseparable connection
Hino, K., Yanatori, I., Hara, Y., & Nishina, S. (2021) · FEBS Journal · doi:10.1111/febs.16208 · Cited by 68
Ackerman, D., & Gems, D. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002498 · Cited by 73
Influence of low oxygen tensions on macrophage polarization
Escribese, M. M., Casas, M., & Corbí, A. L. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.002 · Cited by 69
Thrombopoietin receptor–independent stimulation of hematopoietic stem cells by eltrombopag
Kao, Y.-R., Chen, J., Narayanagari, S.-R., Todorova, T. I., Aivalioti, M. M., Ferreira, M. D. S., Ramos, P. M., Pallaud, C., Mantzaris, I., Shastri, A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aas9563 · Cited by 71
Metadata
- Authors
- Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S.
- Affiliations
- University of California San Diego (US)
- Scripps Research Institute (US)
- University of Pennsylvania (US)
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-07-02
- Volume
- 117
- Issue
- 7
- Pages
- 1926-1932
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1884690
- OpenAlex
- W2116374020
- Cited by
- 639
- References
- 36
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 19 · 2023: 25 · 2022: 26 · 2021: 34 · 2020: 32 · 2019: 18 · 2018: 36 · 2017: 28 · 2016: 31 · 2015: 30 · 2014: 35 · 2013: 39 · 2012: 43
- FWCI
- 33.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA100787)
- National Institute of Allergy and Infectious Diseases (AI060840, R01AI060840)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK073467)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- iron homeostasis, hypoxia-inducible factor, VHL, hepcidin, erythropoietin, ferroportin, iron mobilization, erythropoiesis, anemia, iron overload, hypoxia
- MeSH terms
- Ferroportin, Albumins, Animals, Base Sequence, Homeostasis, Humans, Iron, Liver, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Polycythemia, Promoter Regions, Genetic, Protein Binding, Down-Regulation, Up-Regulation, Gene Deletion, Integrases, Hepatocytes, Antimicrobial Cationic Peptides, Cation Transport Proteins, Mice, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
